BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Figure 5
Figure 5 Melatonin and AZD2171 inhibited angiogenesis in vitro. A: Western blotting of VEGFR-2 and its phosphorylated form in human umbilical vein endothelial cells (HUVECs) treated with VEGFA, melatonin (MLT), or AZD2171; B: Quantitative analysis of VEGFR-2 phosphorylation; C: The proliferation assay of HUVECs treated with VEGFA, MLT, or AZD2171; D: The tube formation assay of HUVECs treated with VEGFA, MLT, or AZD2171; E: Quantitative analysis of tube formation assay; F: The wound healing assay of HUVECs treated with VEGFA, MLT, or AZD2171; G: Quantitative analysis of wound healing assay; H: Transwell migration assay of HUVECs treated with VEGFA, MLT, or AZD2171; I: Quantitative analysis of Transwell migration assay. aP < 0.05. bP < 0.01. MLT: Melatonin.


Write to the Help Desk